{
    "eid": "2-s2.0-85140960029",
    "title": "Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection",
    "cover-date": "2022-10-18",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antiviral",
        "chronic hepatitis B",
        "TREAT-B",
        "treatment eligibility",
        "treatment guidelines"
    ],
    "authors": [
        "Kessarin Thanapirom",
        "Sirinporn Suksawatamnuay",
        "Panarat Thaimai",
        "Sombat Treeprasertsuk",
        "Piyawat Komolmit",
        "Pisit Tangkijvanich"
    ],
    "citedby-count": 1,
    "ref-count": 27,
    "ref-list": [
        "The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013",
        "Global elimination of chronic hepatitis",
        "Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China",
        "The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: a systematic review and meta-analysis",
        "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance",
        "EASL 2017 CLINICAL practice guidelines on the management of hepatitis B virus infection",
        "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update",
        "Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach",
        "Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa",
        "Assessment and simplification of treatment eligibility among patients with chronic hepatitis B infection in Vietnam",
        "Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi",
        "A novel score to select patients for treatment in chronic hepatitis B: results from a large Ethiopian cohort",
        "Performance of two simplified HBV treatment criteria (TREAT-B score and WHO guidelines) in Burkina Faso, West Africa",
        "Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age",
        "Predicting treatment eligibility for hepatitis B in low income regions: can treatment scores without HBV DNA testing serve the purpose?",
        "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study",
        "What is the normal serum alanine aminotransferase (ALT) value for Thai subjects with the low risk of liver diseases?",
        "Basic principles of ROC analysis",
        "Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach",
        "Report of a WHO consultation",
        "Towards the elimination of viral hepatitis in Thailand by the year 2030",
        "Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Liver Diseases",
        "Liver Fibrosis",
        "Medical Council of Thailand",
        "Ratchadapiseksompotch Endowment Fund",
        "Ratchadapiseksompotch Endowment Fund of Liver Fibrosis",
        "Royal College of Physicians of Thailand",
        "Thai Association for the Study of Liver",
        "Thai Red Cross Society",
        "King Chulalongkorn Memorial Hospital",
        "Division of Gastroenterology and Hepatology",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University",
        "Thailand Science Research and Innovation Fund"
    ]
}